ICM
ILMN icon

Invenomic Capital Management’s Illumina ILMN Stock Holding History

Invenomic Capital Management’s Portfolio ILMN Stock Details ILMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-48,224
Closed -$6.29M – 171
2024
Q3 		$6.29M Sell
48,224
-255,365
-84% -$31.5M 0.35% 86
2024
Q2 		$31.7M Buy
303,589
+189,796
+167% +$21.3M 1.54% 15
2024
Q1 		$15.2M Sell
113,793
-240,864
-68% -$32.3M 0.81% 46
2023
Q4 		$48M Buy
+354,657
New +$40.9M 2.19% 6
2022
Q4 		– Sell
-95,198
Closed -$17.7M – 151
2022
Q3 		$17.7M Buy
+95,198
New +$18.8M 1.52% 19

Other funds holding ILMN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Invenomic Capital Management's ILMN Position: Q4 2024 in Review

Invenomic Capital Management sold out of Illumina (ILMN) in Q4 2024, closing a stake of 48,224 shares — an estimated $6.29M sold.

Invenomic Capital Management first reported a position in ILMN in Q3 2022 and held it in 5 quarters. The position peaked at $48M in Q4 2023. 854 funds tracked by Wall St. Rank hold ILMN as of Q4 2024.

  • Invenomic Capital Management reported no remaining Illumina position as of Q4 2024 after selling out during the quarter.
  • Invenomic Capital Management sold 48,224 Illumina shares in Q4 2024, an estimated $6.29M.
  • Invenomic Capital Management first reported a position in Illumina in Q3 2022 and held it in 5 quarters.
  • Invenomic Capital Management's Illumina position peaked at $48M in Q4 2023.
  • 854 funds tracked by Wall St. Rank held Illumina as of Q4 2024.

Based on Invenomic Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.